UBS OCONNOR LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,798,619
-2.7%
25,7350.0%0.04%
-22.4%
Q2 2023$1,849,317
+32.9%
25,735
+14.0%
0.06%
+34.9%
Q1 2023$1,391,871
-99.4%
22,566
+351.3%
0.04%
+975.0%
Q3 2022$223,000,000
-79.2%
5,000
-82.2%
0.00%
-75.0%
Q2 2022$1,073,000,00028,0260.02%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders